Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E. (Q39747931)

14 September 2017

Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E. (English)

1 reference

14 September 2017

1 reference

1 reference

P Soubeyran

5

0 references

author name string

C Andrieu

1

1 reference

14 September 2017

D Taieb

2

1 reference

14 September 2017

V Baylot

3

1 reference

14 September 2017

S Ettinger

4

1 reference

14 September 2017

A De-Thonel

6

1 reference

14 September 2017

C Nelson

7

1 reference

14 September 2017

C Garrido

8

1 reference

14 September 2017

A So

9

1 reference

14 September 2017

L Fazli

10

1 reference

14 September 2017

F Bladou

11

1 reference

14 September 2017

M Gleave

12

1 reference

14 September 2017

J L Iovanna

13

1 reference

14 September 2017

P Rocchi

14

1 reference

14 September 2017

language of work or name

English

0 references

publication date

18 January 2010

1 reference

14 September 2017

1 reference

14 September 2017

29

1 reference

14 September 2017

13

1 reference

14 September 2017

1883-1896

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2009.479

14 September 2017

0 references

cites work

4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Identification of the ubiquitin-proteasome pathway in the regulation of the stability of eukaryotic elongation factor-2 kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

When translation meets transformation: the mTOR story

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Treatment options in hormone-refractory metastatic prostate carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Hormone-refractory prostate cancer: a shifting paradigm in treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

HSP27 and HSP70: potentially oncogenic apoptosis inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Targeting the eukaryotic translation initiation factor 4E for cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Cell cycle-dependent phosphorylation of the translational repressor eIF-4E binding protein-1 (4E-BP1)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Gastrosplenic fistula from Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Interaction between beta-amyloid and lens alphaB-crystallin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

The case for early chemotherapy for the treatment of metastatic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

eIF4E--from translation to transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Small-Molecule Targeting of Heat Shock Protein 90 Chaperone Function: Rational Identification of a New Anticancer Lead

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Lesion macrophages are a key target for the antiatherogenic effects of LXR agonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

The proteasome--an emerging therapeutic target in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Ubiquitination and proteasome-dependent degradation of human eukaryotic translation initiation factor 4E.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Growth inhibition of head and neck squamous carcinoma cells by small interfering RNAs targeting eIF4E or cyclin D1 alone or combined with cisplatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Eukaryotic translation initiation factor 4E is a cellular target for toxicity and death due to exposure to cadmium chloride

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

HSP27 favors ubiquitination and proteasomal degradation of p27Kip1 and helps S-phase re-entry in stressed cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

mTOR signaling: implications for cancer and anticancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Ubiquitin enters the new millennium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Rational design of shepherdin, a novel anticancer agent.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Regulation of cap-dependent translation by eIF4E inhibitory proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Molecular analysis integrating different pathways associated with androgen-independent progression in LuCaP 23.1 xenograft

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

31 March 2020

Identifiers

DOI

10.1038/ONC.2009.479

1 reference

14 September 2017

1 reference